Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IFM Therapeutics
Biotech
Novartis hits the cGAS, taking up option to buy IFM unit
Novartis has pulled the trigger on its option, paying $90 million upfront for small molecules that inhibit the cGAS-STING pathway.
Nick Paul Taylor
Mar 13, 2024 9:01am
Scorpion debuts with $108M to 'put the sting in cancer'
Oct 26, 2020 6:00am
Magenta CSO Michael Cooke jumps to IFM Therapeutics
Jan 7, 2020 10:19am
IFM gets new CEO, bags another $55M to launch incubator
Dec 2, 2019 6:30am
